30 May 2025
Intervengine is reshaping the future of healthcare by delivering faster, more effective, and more affordable preventive health solutions—without relying on traditional investment. This New Zealand-based company has taken a self-funded path, growing through strong customer
traction and strategic partnerships. Rather than seeking early-stage capital, Intervengine has embedded its clinically validated digital health interventions into employee assistance programs (EAPs), digital health start-ups, primary care, and allied health,
while seeking traction with health insurance platforms. By offering white-labelled digital architecture, the company enables other digital start-ups to bypass costly development, saving millions while creating a recurring revenue stream to fund its own operations.
At its core, Intervengine blends behavioural science, AI-driven technology, and human coaching to tackle whole-of-health challenges. Its high-engagement mobile platform delivers daily health insights, activity scores, and AI-generated tips—working seamlessly for both wearable
and non-wearable users. This hybrid care model triples the caseload capacity of health coaches and delivers outcomes up to three times faster than traditional approaches. With licensed, evidence-based interventions from global experts like Professor Judy Moskowitz
of Northwestern University, Intervengine’s programs have demonstrated over 20% improvements in wellbeing. With 40% of its revenue now coming from offshore markets and a growing reputation built through global partnerships and conferences, Intervengine proves
that impactful, export-ready health tech can be built sustainably—and independently—from Aotearoa.